CDT Equity (CDT) announced that, following its strategic review of the cryptocurrency and stablecoin market, engagement with third-party consultants and conversations with stakeholders, the Board has approved a cryptocurrency-based treasury reserve strategy to hold part of its current balance sheet, diversifying its capital management approach for the Company’s assets. The decision reflects the Company’s conviction that long-term exposure to digital assets presents both strategic and financial benefits for investors. As of September 2, 2025, the total number of shares of common stock outstanding was 3,382,025 and the total authorized shares of common stock are 250,000,000 shares. CDT continues to utilize its at-the-market facility with A.G.P./Alliance Global Partners as its primary source of funding.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDT:
- CDT Equity identifies new biological target for AZD1656
- Conduit Pharmaceuticals Rebrands to CDT Equity Inc.
- Conduit Pharmaceuticals to change name to CDT Equity
- Conduit Pharmaceuticals files to sell 255K shares of common stock for holders
- Conduit Pharmaceuticals to explore cryptocurrency reserve strategy